← Back to all clusters

Cluster 257

7 diseases · 15 shared-gene connections
7 Diseases
10 Unique genes
0.330 Avg. similarity score
Arteriovenous hemangioma Most-connected disease (5 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Arteriovenous hemangioma 5 5 4
Blue rubber bleb nevus syndrome 5 5 2
Bockenheimer syndrome 5 5 1
Mucocutaneous venous malformations 5 5 1
TEK-related primary glaucoma 5 5 1
Venous malformation 3 3 2
Congenital venous anomaly 2 2 7

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
TEK 7 / 7 Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Bockenheimer syndrome, Congenital venous anomaly and 3 more
GLMN 3 / 7 Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Congenital venous anomaly
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Tie2 Signaling Reactome 3 / 18 200× 3.37e-7 1.90e-5 ✓ sig.
Downstream signal transduction Reactome 3 / 29 124× 1.50e-6 6.93e-5 ✓ sig.
Axon guidance KEGG 4 / 183 26.3× 1.02e-5 3.41e-4 ✓ sig.
GnRH secretion KEGG 3 / 65 55.4× 1.77e-5 5.40e-4 ✓ sig.
Signaling by FGFR3 fusions in cancer Reactome 2 / 10 240× 2.80e-5 7.86e-4 ✓ sig.
Ras signaling pathway KEGG 4 / 237 20.3× 2.83e-5 7.93e-4 ✓ sig.
Signaling by FGFR4 in disease Reactome 2 / 11 218× 3.42e-5 9.32e-4 ✓ sig.
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants Reactome 2 / 12 200× 4.10e-5 1.09e-3 ✓ sig.
Signaling by PDGFRA extracellular domain mutants Reactome 2 / 12 200× 4.10e-5 1.09e-3 ✓ sig.
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases Reactome 2 / 14 172× 5.65e-5 1.41e-3 ✓ sig.
VEGFR2 mediated cell proliferation Reactome 2 / 14 172× 5.65e-5 1.41e-3 ✓ sig.
Constitutive Signaling by EGFRvIII Reactome 2 / 15 160× 6.51e-5 1.58e-3 ✓ sig.
Signaling by ERBB2 ECD mutants Reactome 2 / 16 150× 7.44e-5 1.76e-3 ✓ sig.
Cholinergic synapse KEGG 3 / 115 31.3× 9.77e-5 2.21e-3 ✓ sig.
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Reactome 2 / 19 126× 1.06e-4 2.36e-3 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
angiogenesis GO:0001525 5 / 284 32.9× 1.85e-7 2.03e-5 ✓ sig.
vasculogenesis GO:0001570 3 / 63 89.0× 4.31e-6 2.66e-4 ✓ sig.
positive regulation of Rac protein signal transduction GO:0035022 2 / 18 208× 3.93e-5 1.50e-3 ✓ sig.
negative regulation of neuron apoptotic process GO:0043524 3 / 160 35.0× 7.07e-5 2.34e-3 ✓ sig.
regulation of actin filament polymerization GO:0030833 2 / 31 121× 1.19e-4 3.45e-3 ✓ sig.
sprouting angiogenesis GO:0002040 2 / 37 101× 1.70e-4 4.50e-3 ✓ sig.
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction GO:0051897 3 / 217 25.8× 1.75e-4 4.59e-3 ✓ sig.
regulation of intracellular signal transduction GO:1902531 2 / 40 93.4× 1.99e-4 5.03e-3 ✓ sig.
ephrin receptor signaling pathway GO:0048013 2 / 51 73.3× 3.24e-4 7.07e-3 ✓ sig.
heart development GO:0007507 3 / 273 20.5× 3.43e-4 7.36e-3 ✓ sig.
heart morphogenesis GO:0003007 2 / 61 61.3× 4.64e-4 9.10e-3 ✓ sig.
cell migration GO:0016477 3 / 303 18.5× 4.65e-4 9.12e-3 ✓ sig.
integrin biosynthetic process GO:0045112 1 / 1 1,869× 5.35e-4 9.98e-3 ✓ sig.
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis GO:1905310 1 / 1 1,869× 5.35e-4 9.98e-3 ✓ sig.
regulation of cell proliferation involved in heart morphogenesis GO:2000136 1 / 1 1,869× 5.35e-4 9.98e-3 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Arteriovenous hemangioma Blue rubber bleb nevus syndrome 0.400 2 5.06e-8 3.92e-7 ✓ sig.
Blue rubber bleb nevus syndrome Congenital venous anomaly 0.250 2 1.77e-7 1.25e-6 ✓ sig.
Arteriovenous hemangioma Congenital venous anomaly 0.200 2 1.06e-6 6.56e-6 ✓ sig.
Bockenheimer syndrome Mucocutaneous venous malformations 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Bockenheimer syndrome TEK-related primary glaucoma 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Mucocutaneous venous malformations TEK-related primary glaucoma 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Blue rubber bleb nevus syndrome Bockenheimer syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Blue rubber bleb nevus syndrome Mucocutaneous venous malformations 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Blue rubber bleb nevus syndrome TEK-related primary glaucoma 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Bockenheimer syndrome Venous malformation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Mucocutaneous venous malformations Venous malformation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
TEK-related primary glaucoma Venous malformation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Arteriovenous hemangioma Bockenheimer syndrome 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Arteriovenous hemangioma Mucocutaneous venous malformations 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Arteriovenous hemangioma TEK-related primary glaucoma 0.200 1 2.60e-4 6.40e-4 ✓ sig.